Anti-aging peptides represent the most intellectually rich and fastest-growing sector of the research peptide field. Unlike body composition peptides with relatively direct mechanisms, anti-aging peptides work through foundational biological processes: telomere maintenance, mitochondrial function, epigenetic regulation, and immune system rejuvenation. The timeline for effects is measured in months and years rather than days and weeks — but the biological mechanisms are among the most interesting in longevity science.
Research context only. The peptides discussed on WolveStack are research chemicals not approved for human use by the FDA. Nothing on this page constitutes medical advice. Consult a qualified healthcare professional before use.
Most practitioners suggest the longevity-focused peptides (Epithalon, MOTS-c, Humanin) are most impactful starting at 35–40+ when age-related declines in telomerase, mitochondrial function, and GH secretion become significant. GHK-Cu and GH secretagogues have relevant applications at any age. Using Epithalon in one's 20s, when telomerase is already active, provides less relative benefit than supplementing in later decades when it is declining.
Epithalon: The Telomere Peptide
Epithalon (Epitalon) is a tetrapeptide (Ala-Glu-Asp-Gly) originally isolated from the bovine pineal gland by Vladimir Khavinson's research group in Russia. Its primary mechanism involves activation of telomerase — the enzyme that elongates telomeres, the protective end-caps of chromosomes that shorten with every cell division and serve as a biological clock for cellular aging. Epithalon is the only peptide with published human data on telomere extension.
In a landmark clinical study, elderly patients treated with Epithalon showed telomere lengthening and reduced markers of cellular aging compared to controls. Animal studies show lifespan extension in fruit flies and rodents. The pineal gland modulation mechanism (Epithalon stimulates melatonin secretion and normalises circadian regulation) provides additional mechanisms beyond telomerase — sleep quality improvement, antioxidant effects, and immune normalisation.
GHK-Cu and MOTS-c: Gene Expression and Mitochondrial Health
GHK-Cu (copper peptide GHK-Cu) acts as a gene expression regulator at a remarkable scale — research by Loren Pickart identified over 4,000 human genes whose expression GHK-Cu modulates. The pattern is consistently anti-aging: upregulation of repair and protection genes (antioxidant enzymes, collagen synthesis, anti-inflammatory signals) and downregulation of disease-associated genes (inflammatory, pro-fibrotic, cancer-related). GHK-Cu's anti-aging profile extends from skin (the most visible application) to systemic tissue repair and potentially cognitive protection.
MOTS-c is a peptide encoded in mitochondrial DNA — a natural signalling molecule that regulates mitochondrial function, AMPK activation, and metabolic homeostasis. Mitochondrial dysfunction is a primary driver of cellular aging (the mitochondrial theory of aging), and MOTS-c's ability to improve mitochondrial biogenesis and efficiency addresses this directly. Animal studies show improved exercise capacity, metabolic health, and lifespan extension with MOTS-c.
Humanin and the Mitochondrial Peptide Family
Humanin is another mitochondrial-derived peptide with cytoprotective effects — it protects cells from apoptosis (programmed cell death) driven by a range of stressors including oxidative stress, beta-amyloid toxicity (relevant to Alzheimer's), and ischemia. Humanin levels decline with age and are inversely correlated with cardiovascular disease risk in population studies. Its combination with MOTS-c targets mitochondrial aging from two complementary angles.
The emerging picture from mitochondrial peptide research is that MOTS-c, Humanin, and related small mitochondrial open reading frame peptides (MOTS-c is actually one of the MOTS family) collectively regulate the communication between mitochondria and the nucleus — a signalling axis central to the hallmarks of aging. Supplementing these peptides as levels decline with age is an increasingly rational longevity strategy with an improving evidence base.
Anti-Aging Peptides Compared
| Peptide | Dose | Route | Frequency | Notes |
|---|---|---|---|---|
| Epithalon | 5–10 mg/day | SubQ | 10–20 day course, 1–2x/year | Telomere extension; pineal modulation |
| GHK-Cu (systemic) | 1–2 mg | SubQ | 3–5x/week | Gene expression anti-aging profile |
| GHK-Cu (topical) | 0.1–1% | Topical | Twice daily | Skin anti-aging; direct application |
| MOTS-c | 5–10 mg | SubQ | 3x/week | Mitochondrial function; metabolic health |
| Humanin | 2–4 mg | SubQ | 3x/week | Cytoprotection; cardiovascular and neural |
| Ipamorelin/CJC-1295 | 200 mcg each | SubQ pre-sleep | Daily (8-week cycles) | GH restoration; body composition anti-aging |
Research-Grade Sourcing
WolveStack partners with Ascension Peptides for independently third-party tested research compounds with published COAs. The links below go directly to the relevant products.
For research purposes only. Affiliate disclosure: WolveStack earns a commission on qualifying purchases at no additional cost to you.
Also Available at Apollo Peptide Sciences
Apollo Peptide Sciences carries independently tested research-grade compounds. Products ship from the USA with published purity certificates.
For research purposes only. Affiliate disclosure: WolveStack earns a commission on qualifying purchases at no additional cost to you.
Frequently Asked Questions
Epithalon has the most unique mechanism (telomerase activation with human clinical data) and arguably the most fundamental approach to biological aging. GHK-Cu offers the broadest anti-aging gene expression profile. MOTS-c addresses the mitochondrial theory of aging directly. A comprehensive anti-aging protocol uses all three through their complementary, non-overlapping mechanisms.
Epithalon is typically run in a 10–20 day course of daily injections, then repeated 1–2 times per year. The telomere-related effects are not acutely perceptible — they are measured in blood markers. Subjective effects commonly reported include improved sleep quality and vivid dreaming (via pineal modulation), improved skin quality, and a general sense of wellbeing. These begin during the course and may continue for months after.
No peptide currently available reverses aging in the sense of restoring a young biological state. What anti-aging peptides can do: slow certain aspects of biological aging (telomere attrition via Epithalon), improve markers of biological age (inflammatory markers via GHK-Cu), enhance mitochondrial function (MOTS-c, Humanin), and restore age-declined GH levels (secretagogues). The evidence for meaningful lifespan extension is strong in animal models but remains unproven in humans.
Most practitioners suggest the longevity-focused peptides (Epithalon, MOTS-c, Humanin) are most impactful starting at 35–40+ when age-related declines in telomerase, mitochondrial function, and GH secretion become significant. GHK-Cu and GH secretagogues have relevant applications at any age. Using Epithalon in one's 20s, when telomerase is already active, provides less relative benefit than supplementing in later decades when it is declining.
Epithalon's course-based administration (rather than continuous use) reduces long-term safety concerns. GHK-Cu has an excellent safety profile from both topical and systemic use. MOTS-c and Humanin have shorter track records in human use. The general principle: intermittent cycling is preferred to continuous administration for any peptide, and regular blood markers (full metabolic panel, CBC, inflammatory markers) provide meaningful safety monitoring.